Senior Director Health Economics and Outcomes Research (HEOR)

J oin Us in Tackling Autoimmune Disease at Its Root At Vor, we believe science can do more than manage symptoms. It can change the course of disease. By advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor, we are silencing upstream survival signals and stopping downstream autoimmune cascades. Together, we are addressing disease at its root cause and rewriting what is possible for patients worldwide. When you join Vor, you’re not just working on a medicine. You’re part of a mission to redefine the future of autoimmune care. Why Work at Vor? Impact: Contribute directly to a medicine with best-in-disease Phase 3 results in myasthenia gravis and expansion into multiple autoimmune diseases. Growth: Be part of a rapidly scaling company with opportunities to grow your career in science, clinical development, commercial strategy, and beyond. Innovation: Work on a platform with potential beyond one indication — a therapy that has already shown consistent results across lupus, IgA nephropathy, and Sjögren’s syndrome. Belonging: Join a culture where every voice is heard, and where our shared mission unites us across functions and geographies. Location: Boston, MA preferred Role Summary The Senior Director, HEOR leads the strategy and execution of health economics, real‑world evidence (RWE), and value demonstration activities to support global and US market access for the company’s lead asset(s). Operating in a resource‑lean, fast‑moving biotech , this leader builds the HEOR function from the ground up, partners cross‑functionally to shape clinical and evidence strategy, and ensures that payers, HTA bodies, clinicians, and patient communities understand the clinical, economic, and humanistic value of the therapy—especially critical in rare or high‑unmet‑need diseases. We are looking for a hands-on leader who can both set strategy and execute who is a patient-centric thinker. In this role you will need to anticipate payer needs and shape development accordingly. This role reports to the Chief Medical Affairs Officer and is a key contributor to launch readiness. Key Responsibilities HEOR Strategy & Leadership Develop and own the global and US HEOR strategy , aligned with clinical development, Medical Affairs, and Market Access priorities. Build a fit‑for‑purpose HEOR roadmap including burden of illness, cost‑of‑illness, treatment patterns, PRO strategy, economic models, and RWE plans. Serve as the internal expert on value, evidence, and payer expectations , advising senior leadership on implications for development and commercialization. Evidence Generation & RWE Design and oversee RWE studies , including natural history studies, chart reviews, registries, and external data collaborations. Lead development and validation of patient‑reported outcomes (PROs) and other clinical outcome assessments (COAs) for regulatory and payer use. Partner with Clinical Development to ensure trial designs incorporate endpoints relevant to payers, HTA bodies, and patient communities. Manage vendors conducting HEOR and RWE studies; ensure scientific rigor, compliance, and timely delivery. Value Demonstration & Market Access Support Lead development of global value dossiers (GVDs) , AMCP dossiers, payer evidence decks, and HTA submissions. Build and maintain cost‑effectiveness models, budget impact models , and scenario analyses to support pricing and reimbursement. Provide HEOR insights to pricing strategy , including value‑based pricing rationale and competitive landscape assessments. Support payer and HTA engagements with evidence, models, and scientific responses. Cross‑Functional Collaboration Partner closely with Medical Affairs on evidence generation, publications, and scientific exchange. Collaborate with Market Access on payer strategy, pull‑through materials, and field training. Work with Patient Advocacy to ensure patient‑centric evidence and outcomes are incorporated into HEOR plans. Engage with Regulatory Affair